In a few seven night, double-blind, parallel-group trials comparing Estazolam 1 mg and/or two mg with placebo in Grownup outpatients with Serious insomnia, Estazolam 2 mg was consistently superior to placebo in subjective measures of slumber induction (latency) and slumber maintenance (period, quantity of awakenings, depth and quality of slumber);